Impact of Pre-Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating Agents.

ABSTRACT: Expectation of survival of patients receiving HMA + VEN is influenced by pre-treatment comorbidity burden.

SUBMITTER: Marconi G 

PROVIDER: S-EPMC11886493 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature